New AACE Clinical Practice Guidelines for Diagnosis and Management of Hyperthyroidism Highlighted During Thyroid Awareness Month

Publish Date:

Tuesday, January 17, 2012 3:00 am EST


JACKSONVILLE, Fla.-- New clinical guidelines for optimal care of patients with hyperthyroidism, a condition when the thyroid gland produces more thyroid hormone than the body needs, which affects about one percent of  Americans, are being presented by the American Association of Clinical Endocrinologists (AACE) as part of January being Thyroid Awareness Month.

The guidelines, developed jointly by AACE and the American Thyroid Association (ATA), were originally published last June in Endocrine Practice, the journal of the American Association of Clinical Endocrinologists (AACE). The Hyperthyroidism guidelines are available free online.
Key updates in the guidelines involve the treatment of Graves’ disease. This condition, which may cause eye protrusion, is the most common form of hyperthyroidism. 
“The new guidelines review well-established treatment options for Graves’ Disease, while emphasizing how and when physicians should take their patients’ preference into consideration,” said Daniel S. Duick, MD, FACP, FACE, Past President of AACEand President of the American College of Endocrinology.
The guidelines also present new approaches to managing Graves’ eye disease; subclinical hyperthyroidism, the term for mild or early forms of hyperthyroidism; and which drugs are now preferred to treat the various forms of hyperthyroidism.
“Our goal with these new guidelines is to provide every doctor treating thyroid patients the tools they need to provide the most effective care,” said Yehuda Handelsman, MD, FACP, FACE, FNLA, and President of the American Association of Clinical Endocrinologists. “Today, we have access to more clinical research data than ever before, and these guidelines help put that knowledge in the physicians’ hands.”
Providing physicians and patients with the greatest access to the best care and education on thyroid disease is a core mission for AACE. This is the 18th consecutive year AACE has sponsored January as Thyroid Awareness Month, helping to raise awareness about early detection and proper treatment of thyroid disease. More information regarding thyroid awareness is available at
To view the complete AACE Hyperthyroidism guidelines, please Click Here. 

The American Association of Clinical Endocrinologists (AACE)

The American Association of Clinical Endocrinologists (AACE) represents more than 6,500 endocrinologists in the United States and abroad. AACE is the largest association of clinical endocrinologists in the world. The majority of AACE members are certified in Endocrinology and Metabolism and concentrate on the treatment of patients with endocrine and metabolic disorders including diabetes, thyroid disorders, osteoporosis, growth hormone deficiency, cholesterol disorders, hypertension and obesity. For more information about AACE, visit the AACE website at, become a fan on Facebook at or follow AACE on Twitter at